Paradigm Asset Management
VRTX icon

Paradigm Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Paradigm Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$340K Hold
650
– – 0.08% 221
2026
Q2 		$323K Buy
650
+300
+86% +$133K 0.07% 234
2026
Q1 		$156K Hold
350
– – 0.04% 289
2025
Q4 		$159K Hold
350
– – 0.04% 297
2025
Q3 		$137K Hold
350
– – 0.03% 294
2025
Q2 		$156K Sell
350
-100
-22% -$46.1K 0.04% 285
2025
Q1 		$218K Hold
450
– – 0.06% 252
2024
Q4 		$181K Buy
450
+200
+80% +$92.7K 0.05% 273
2024
Q3 		$116K Hold
250
– – 0.03% 313
2024
Q2 		$117K Sell
250
-200
-44% -$86.8K 0.03% 307
2024
Q1 		$188K Sell
450
-150
-25% -$63.4K 0.05% 298
2023
Q4 		$244K Hold
600
– – 0.06% 283
2023
Q3 		$209K Hold
600
– – 0.06% 290
2023
Q2 		$211K Buy
+600
New +$202K 0.06% 288
2017
Q2 		– Sell
-200
Closed -$21.9K – 657
2017
Q1 		$21.9K Sell
200
-450
-69% -$39.6K ﹤0.01% 608
2016
Q4 		$47.9K Sell
650
-1,200
-65% -$97.6K 0.01% 496
2016
Q3 		$161K Buy
1,850
+400
+28% +$37.8K 0.03% 341
2016
Q2 		$125K Buy
1,450
+249
+21% +$21.5K 0.02% 386
2016
Q1 		$95.5K Buy
1,201
+51
+4% +$4.61K 0.02% 471
2015
Q4 		$145K Sell
1,150
-200
-15% -$24.1K 0.02% 402
2015
Q3 		$141K Sell
1,350
-3,650
-73% -$469K 0.02% 483
2015
Q2 		$617K Hold
5,000
– – 0.07% 275
2015
Q1 		$590K Buy
+5,000
New +$599K 0.07% 284

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Paradigm Asset Management's VRTX Position: Q3 2026 in Review

Paradigm Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 650 shares worth $340K. The position accounts for 0.08% of the portfolio, ranked #221.

Paradigm Asset Management first reported a position in VRTX in Q1 2015 and has held it in 23 quarters since. The position peaked at $617K in Q2 2015. 982 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Paradigm Asset Management held 650 shares of Vertex Pharmaceuticals worth $340K as of Q3 2026.
  • Paradigm Asset Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.08% of Paradigm Asset Management's portfolio in Q3 2026, its #221 holding.
  • Paradigm Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 23 quarters since.
  • Paradigm Asset Management's Vertex Pharmaceuticals position peaked at $617K in Q2 2015.
  • 982 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Paradigm Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.